Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results